Бронхіальна астма - Міністерство охорони здоров'я України

334. Hawkins G, McMahon AD, Twaddle S, Wood S, Ford I, NC. T. Stepping down inhaled corticosteroidsin asthma: randomised controlled trial. BMJ 2003;326(7399):1115.335. Pharmacological management of asthma. Evidence table 4.9: Exacerbation. Edinburgh: SIGN; 2002.Available from url: http://www. sign.ac.uk/guidelines/published/support/guideline63/index.html336. Reference deleted337. Henriksen JM, Agertoft L, Pedersen S. Protective effect and duration of action of inhaled formoteroland salbutamol on exercise-induced asthma in children. J Allergy Clin Immunol 1992;89(6):1176-82.338. Pharmacological management of asthma. Evidence table 4.3a: Long acting B2 agonists in exerciseinduced asthma. Edinburgh: SIGN; 2002. Available from url:http://www.sign.ac.uk/guidelines/published/support/guideline63/index.html339. Pharmacological management of asthma. Evidence table 4.3c:Theophyllines in exercise-inducedasthma. Edinburgh: SIGN; 2002.Available from url: http://www.sign.ac.uk/guidelines/published/support/guideline63/index.html340. Pharmacological management of asthma. Evidence table 4.3d: Leukotriene receptor antagonists inexercise induced asthma. Edinburgh: SIGN; 2002. Available from url:http://www.sign.ac.uk/guidelines/published/support/guideline63/index.html341. Kelly K, Spooner CH, Rowe BH. Nedocromil sodium versus sodium cromoglycate for preventingexercise-induced bronchoconstriction in asthmatics (Cochrane Review). In: The Cochrane Library, Issue 3,2001. London: John Wiley & Sons Ltd.342. Pharmacological management of asthma. Evidence table 4.3g: Oral B2 agonists for exercise inducedasthma. Edinburgh: SIGN; 2002. Available from url: http://www.sign.ac.uk/guidelines/published/support/guideline63/index.html343. Pharmacological management of asthma. Evidence table 4.3f: Anticholinergic therapy for exerciseinducedasthma. Edinburgh: SIGN; 2002. Available from url: http://www.sign.ac.uk/guidelines/published/support/guideline63/index.html344. Pharmacological management of asthma. Evidence table 4.3b: Ketotifen for exercise-induced asthma.Edinburgh: SIGN; 2002. Available from url:http://www.sign.ac.uk/guidelines/published/support/guideline63/index.html345. Pharmacological management of asthma. Evidence table 4.3e: Antihistamines for exercise-inducedasthma. Edinburgh: SIGN; 2002. Available from url: http://www.sign.ac.uk/guidelines/published/support/guideline63/index.html346. Pharmacological management of asthma. Evidence table 4.10: Rhinitis. Edinburgh: SIGN; 2002.Available from url: http://www.sign.ac.uk/guidelines/published/support/guideline63/index.html347. Pharmacological management of asthma. Evidence table 4.19: Allergic bronchopulmonaryaspergillosis. Edinburgh: SIGN; 2002. Available from url:http://www.sign.ac.uk/guidelines/published/support/guideline63/index.html348. Wark PAB, Gibson PG, Wilson AJ. Azoles for allergic bronchopulmonary aspergillosis associated withasthma (Cochrane Review). In: The Cochrane Library, Issue 3, 2004. London: John Wiley & Sons Ltd.349. Pharmacological management of asthma. Evidence table 4.21: Aspirin intolerant asthma. Edinburgh:SIGN; 2002. Available from url: http://www.sign.ac.uk/guidelines/published/support/guideline63/index.html350. Coughlan J. Oesophagitis does not consistently improve asthma control: A systematic review. . Thorax2001;56(3):198-204.351. Gibson PG, Henry RL, Coughlan JL. Gastro oesophogeal reflux treatment for asthma in adults andchildren (Cochrane Review). In: The Cochrane Library, Issue 2, 2003. London: John Wiley & Sons352. Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, et al. Comparison of the effectiveness ofinhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.Health Technol Assess 2001;5(26):1-149.353. Cates CJ, Rowe BH, Bara A, Crilly JA. Holding chambers versus nebulisers for beta-agonist treatmentof acute asthma (Cochrane Review). In: The Cochrane Library, Issue 3, 2001. London: John Wiley & SonsLtd.354. Leversha AM, Campanella SG, Aickin RP, Asher MI. Costs and effectiveness of spacer versusnebuliser in young children with moderate and severe acute asthma. J Pediatr 2000;136(4):497-502.243